ROTATEQ, solution buvable. Vaccin Rotavirus (vivant, oral) — 1 tube unidose souple polyéthylène basse densité (PEBD) suremballée(s)/surpochée(s) de 2 ml

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400937622363
  • CIP7 3762236
  • CIS 66396810
  • Registration number EU/1/06/348

What the source publishes

Holder
MERCK SHARP & DOHME (PAYS-BAS)
Active ingredients
ROTAVIRUS RÉASSORTANT HUMAIN-BOVIN DE TYPE G1 (VIVANT), ROTAVIRUS RÉASSORTANT HUMAIN-BOVIN DE TYPE G2 (VIVANT), ROTAVIRUS RÉASSORTANT HUMAIN-BOVIN DE TYPE G3 (VIVANT), ROTAVIRUS RÉASSORTANT HUMAIN-BOVIN DE TYPE G4 (VIVANT), ROTAVIRUS RÉASSORTANT HUMAIN-BOVIN DE TYPE P1A[8] (VIVANT)
Form
solution buvable
Package
1 tube unidose souple polyéthylène basse densité (PEBD) suremballée(s)/surpochée(s) de 2 ml
Routes
orale
Administrative status
authorised
Supply regime
liste I
Marketing status
Déclaration de commercialisation
Authorised on
2006-06-27
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400937622363
{
  "cis": "66396810",
  "cip7": "3762236",
  "form": "solution buvable",
  "name": "ROTATEQ, solution buvable. Vaccin Rotavirus (vivant, oral) — 1 tube unidose souple polyéthylène basse densité (PEBD) suremballée(s)/surpochée(s) de 2 ml",
  "cip13": "3400937622363",
  "holder": "MERCK SHARP & DOHME (PAYS-BAS)",
  "routes": [
    "orale"
  ],
  "holders": [
    "MERCK SHARP & DOHME (PAYS-BAS)"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "53.18",
  "authorisedOn": "2006-06-27",
  "compositions": [
    {
      "name": "ROTAVIRUS RÉASSORTANT HUMAIN-BOVIN DE TYPE G1 (VIVANT)",
      "nature": "SA",
      "strength": "au minimum 2 200 000 UI",
      "linkageNumber": "1",
      "substanceCode": "20262",
      "dosageReference": "une dose de 2 ml",
      "pharmaceuticalElement": "solution"
    },
    {
      "name": "ROTAVIRUS RÉASSORTANT HUMAIN-BOVIN DE TYPE G2 (VIVANT)",
      "nature": "SA",
      "strength": "au minimum 2 800 000 UI",
      "linkageNumber": "2",
      "substanceCode": "36354",
      "dosageReference": "une dose de 2 ml",
      "pharmaceuticalElement": "solution"
    },
    {
      "name": "ROTAVIRUS RÉASSORTANT HUMAIN-BOVIN DE TYPE G3 (VIVANT)",
      "nature": "SA",
      "strength": "au minimum 2 200 000 UI",
      "linkageNumber": "3",
      "substanceCode": "46263",
      "dosageReference": "une dose de 2 ml",
      "pharmaceuticalElement": "solution"
    },
    {
      "name": "ROTAVIRUS RÉASSORTANT HUMAIN-BOVIN DE TYPE G4 (VIVANT)",
      "nature": "SA",
      "strength": "au minimum 2 000 000 UI",
      "linkageNumber": "4",
      "substanceCode": "57655",
      "dosageReference": "une dose de 2 ml",
      "pharmaceuticalElement": "solution"
    },
    {
      "name": "ROTAVIRUS RÉASSORTANT HUMAIN-BOVIN DE TYPE P1A[8] (VIVANT)",
      "nature": "SA",
      "strength": "au minimum 2 300 000 UI",
      "linkageNumber": "5",
      "substanceCode": "90361",
      "dosageReference": "une dose de 2 ml",
      "pharmaceuticalElement": "solution"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "liste I",
  "dispensingFee": "1.02",
  "medicinePrice": "52.16",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "ROTATEQ, solution buvable. Vaccin Rotavirus (vivant, oral)",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "1 tube unidose souple polyéthylène basse densité (PEBD) suremballée(s)/surpochée(s) de 2 ml",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "65 %"
  ],
  "marketingDeclaredOn": "2007-01-08",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "ROTAVIRUS RÉASSORTANT HUMAIN-BOVIN DE TYPE G1 (VIVANT)",
    "ROTAVIRUS RÉASSORTANT HUMAIN-BOVIN DE TYPE G2 (VIVANT)",
    "ROTAVIRUS RÉASSORTANT HUMAIN-BOVIN DE TYPE G3 (VIVANT)",
    "ROTAVIRUS RÉASSORTANT HUMAIN-BOVIN DE TYPE G4 (VIVANT)",
    "ROTAVIRUS RÉASSORTANT HUMAIN-BOVIN DE TYPE P1A[8] (VIVANT)"
  ],
  "authorisationProcedure": "Procédure centralisée",
  "prescriptionConditions": [
    "liste I"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": "EU/1/06/348",
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400937622363"